X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (264) 264
Patent (221) 221
Newspaper Article (32) 32
Publication (32) 32
Book Review (27) 27
Conference Proceeding (23) 23
Paper (9) 9
Book Chapter (6) 6
Dissertation (3) 3
Book / eBook (2) 2
Magazine Article (2) 2
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
performing operations (110) 110
transporting (110) 110
index medicus (100) 100
humans (93) 93
chemistry (67) 67
metallurgy (66) 66
oncology (59) 59
organic chemistry (59) 59
middle aged (56) 56
male (55) 55
after-treatment of the shaped products, e.g. repairing (54) 54
female (54) 54
shaping of material in a plastic state, not otherwise providedfor (54) 54
shaping or joining of plastics (54) 54
working of plastics (54) 54
working of substances in a plastic state, in general (54) 54
pancreatic cancer (52) 52
general tagging of cross-sectional technologies spanning over several sections of the ipc (45) 45
general tagging of new technological developments (45) 45
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (45) 45
aged (44) 44
human necessities (42) 42
physics (41) 41
adult (40) 40
gemcitabine (38) 38
indexing scheme associated with subclasses b29b, b29c or b29d, relating to moulding materials (38) 38
pancreatic neoplasms - drug therapy (38) 38
physical or chemical processes or apparatus in general (38) 38
hygiene (37) 37
medical or veterinary science (37) 37
acyclic or carbocyclic compounds (36) 36
chemotherapy (36) 36
chemical or physical processes, e.g. catalysis or colloidchemistry (35) 35
their relevant apparatus (35) 35
technologies or applications for mitigation or adaptation againstclimate change (34) 34
survival (33) 33
pancreatic neoplasms - pathology (32) 32
blasting (30) 30
heating (30) 30
lighting (30) 30
mechanical engineering (30) 30
weapons (30) 30
climate change mitigation technologies in the production orprocessing of goods (26) 26
cancer (25) 25
deoxycytidine - analogs & derivatives (25) 25
electricity (25) 25
surgery (25) 25
engineering elements and units (24) 24
general measures for producing and maintaining effectivefunctioning of machines or installations (24) 24
prognosis (24) 24
thermal insulation in general (24) 24
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
heterocyclic compounds (22) 22
indexing scheme associated with subclass b29c, relating to particulararticles (22) 22
preparations for medical, dental, or toilet purposes (22) 22
adenocarcinoma (21) 21
aged, 80 and over (21) 21
carcinoma (21) 21
making granules or preforms (20) 20
preparation or pretreatment of the material to beshaped (20) 20
recovery of plastics or other constituents of waste materialcontaining plastics (20) 20
treatment outcome (19) 19
erlotinib (18) 18
phase-iii trial (18) 18
research (17) 17
survival analysis (17) 17
specific use of cosmetics or similar toiletpreparations (16) 16
adenocarcinoma - drug therapy (15) 15
analysis (15) 15
combustion engines (15) 15
diagnosis (15) 15
hot-gas or combustion-product engine plants (15) 15
pancreatic neoplasms - mortality (15) 15
prospective studies (15) 15
deoxycytidine - therapeutic use (14) 14
gastroenterology & hepatology (14) 14
high energy physics - experiment (14) 14
pharmacology & pharmacy (14) 14
supplying combustion engines in general, with combustiblemixtures or constituents thereof (14) 14
trial (14) 14
electric communication technique (13) 13
joints or fittings for pipes (13) 13
means for thermal insulation in general (13) 13
pipes (13) 13
semiconductor devices (13) 13
supports for pipes, cables or protective tubing (13) 13
therapy (13) 13
adenocarcinoma - pathology (12) 12
basic electric elements (12) 12
electric solid state devices not otherwise provided for (12) 12
health aspects (12) 12
mutation (12) 12
retrospective studies (12) 12
antineoplastic combined chemotherapy protocols - adverse effects (11) 11
deoxycytidine - administration & dosage (11) 11
medicine & public health (11) 11
medizin (11) 11
metastasis (11) 11
technical subjects covered by former uspc (11) 11
apparatus therefor (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lendemains: Etudes Comparées sur la France/Vergleichende Frankreichforschung, ISSN 0170-3803, 01/2012, Volume 37, Issue 146-147, pp. 101 - 117
Journal Article
Publications of the English Goethe Society, ISSN 1749-6284, 2010, Volume 79, Issue 1, p. 5
Journal Article
PUBLICATIONS OF THE ENGLISH GOETHE SOCIETY, ISSN 0959-3683, 03/2010, Volume 79, Issue 1, pp. 5 - 17
Journal Article
Publications of the English Goethe Society, ISSN 0959-3683, 01/2010, Volume 79, Issue 1, pp. 5 - 17
Journal Article
Gut, ISSN 0017-5749, 05/2013, Volume 62, Issue 5, pp. 751 - 759
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 4/2013, Volume 139, Issue 4, pp. 681 - 689
Journal Article
Journal Article
The Lancet, ISSN 0140-6736, 08/2017, Volume 390, Issue 10097, pp. 847 - 848
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(17)31806-8 Byline: Stefan Boeck (a), Volker Heinemann (a) 
ADJUVANT CHEMOTHERAPY | TRIAL | SURVIVAL | SURGERY | MEDICINE, GENERAL & INTERNAL | GEMCITABINE | Watchful Waiting | Prognosis | Humans | Pancreatic Neoplasms - surgery | Pancreatectomy | Pancreatic cancer | Chemotherapy | Postoperative period | Surgery | Cancer therapies | Cancer | Cancer surgery | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article
Journal Article
Pharmacogenomics, ISSN 1462-2416, 10/2012, Volume 13, Issue 13, pp. 1469 - 1476
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2015, Volume 55, pp. 131 - 139
Abstract Aim The aim of this study was to investigate if biomarkers of individual drug metabolism, respectively, the erlotinib/O-desmethyl-erlotinib metabolic... 
Hematology, Oncology and Palliative Medicine | Erlotinib/O-desmethyl-erlotinib ratio | EGFR inhibitor-induced skin rash | Erlotinib metabolic ratio | Predictive biomarker | PLUS GEMCITABINE | MANAGEMENT | PANCREATIC-CANCER | PHASE-III | TOXICITY | CELL LUNG-CANCER | THERAPY | PHARMACOKINETICS | ONCOLOGY | RECEPTOR TYROSINE KINASE | ADVERSE EVENTS | Exanthema - diagnosis | Lung Neoplasms - drug therapy | Predictive Value of Tests | Adenocarcinoma - pathology | Prospective Studies | Lung Neoplasms - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - administration & dosage | Drug Monitoring - methods | Protein Kinase Inhibitors - adverse effects | Exanthema - chemically induced | Aged, 80 and over | Antineoplastic Agents - pharmacokinetics | Protein Kinase Inhibitors - pharmacokinetics | Erlotinib Hydrochloride - adverse effects | Lung Neoplasms - enzymology | Erlotinib Hydrochloride - pharmacokinetics | Adenocarcinoma - blood | Pancreatic Neoplasms - pathology | Adenocarcinoma - drug therapy | Disease Progression | Protein Kinase Inhibitors - blood | Erlotinib Hydrochloride - blood | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Agents - blood | Carcinoma, Non-Small-Cell Lung - enzymology | Germany | Lung Neoplasms - pathology | Pancreatic Neoplasms - drug therapy | Drug Dosage Calculations | Receptor, Epidermal Growth Factor - metabolism | Antineoplastic Agents - adverse effects | Biotransformation | Adult | Female | Pancreatic Neoplasms - mortality | Carcinoma, Non-Small-Cell Lung - pathology | Severity of Illness Index | Pancreatic Neoplasms - blood | Dealkylation | Adenocarcinoma - enzymology | Erlotinib Hydrochloride - administration & dosage | Kaplan-Meier Estimate | Pancreatic Neoplasms - enzymology | Proportional Hazards Models | Carcinoma, Non-Small-Cell Lung - mortality | Disease-Free Survival | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Carcinoma, Non-Small-Cell Lung - blood | Aged | Lung Neoplasms - blood | Carcinoma, Non-Small-Cell Lung - drug therapy | Adenocarcinoma - mortality | Epidermal growth factor | Erlotinib | Skin care products | Physiological aspects | Rash (Dermatology) | Skin | Biological markers | Index Medicus
Journal Article
Journal Article
Nature Genetics, ISSN 1061-4036, 05/2016, Volume 48, Issue 5, pp. 510 - 518
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2013, Volume 31, Issue 35, pp. 4453 - 4461
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2010, Volume 16, Issue 3, pp. 986 - 994
Purpose: The clinical relevance of CA 19-9 as surrogate biomarker in advanced pancreatic cancer is a matter of debate. Experimental Design: This retrospective... 
CA 19-9 | pancreatic cancer | biomarker | chemotherapy | SURVIVAL | PREDICTS | MULTICENTER | ONCOLOGY |